Schrodinger Inc.

Last updated September 27, 2026

Organization details

Legal name
Schrodinger Inc.
Ownership
Public
Status
Active
SIC code
2834 โ€” Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SDGR
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001490978
EIN
95-4284541

Board of directors

Chief executives

Ramy Farid ยท President & CEO
Dates unknown

Director election results

Annual meeting of June 22, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 16 other boards.

Network of Schrodinger Inc.'s board connections Adicet Bio Inc. Adicet Bio Inc. Apnimed Inc. Apnimed Inc. Ares Management Corporation Ares Management Corpor... Denali Therapeutics Inc. Denali Therapeutics In... Harmony Biosciences Holdings Inc. Harmony Biosciences Ho... Paymentus Holdings Inc. Paymentus Holdings Inc... Praxis Precision Medicines Inc. Praxis Precision Medic... Snap Inc. Snap Inc. Structure Therapeutics Inc. Structure Therapeutics... Teradyne Inc. Teradyne Inc. The Travelers Companies Inc. The Travelers Companie... Townsquare Media Inc. Townsquare Media Inc. Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals... Vir Biotechnology Inc. Vir Biotechnology Inc. Warner Music Group Corp. Warner Music Group Cor... iBio Inc. iBio Inc. Arun Oberoi Arun Oberoi Gary L. Ginsberg Gary L. Ginsberg Gary Sender Gary Sender Jeffrey Chodakewitz Jeffrey Chodakewitz Kralingen Bridget A. Van Kralingen Bridget A.... Michael Lynton Michael Lynton Nancy Thornberry Nancy Thornberry Ramy Farid Ramy Farid Schrodinger Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$2,330,221
21 sales by 8 insiders
Date Insider Transaction Shares Price Value
Sep 17, 2026 Karen Akinsanya Officer (See Remarks) Option exercise +31,599 $4.34 $137,140
Sep 17, 2026 Karen Akinsanya Officer (See Remarks) Open-market sale โˆ’10,000 $28.00 $280,000
Sep 17, 2026 Karen Akinsanya Officer (See Remarks) Open-market sale โˆ’21,599 $30.00 $647,970
Jul 16, 2026 Jain Rachit Officer (EVP & CFO) Open-market sale โˆ’875 $15.60 $13,647
Jun 26, 2026 Richard Friesner Director Gift โˆ’679,373 โ€” โ€”
Jun 26, 2026 Richard Friesner Director Gift +679,373 โ€” โ€”
Jun 22, 2026 Arun Oberoi Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Jeffrey Chodakewitz Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Richard Friesner Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Gary L. Ginsberg Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Rosana Kapeller-Libermann Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Michael Lynton Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Gary Sender Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Nancy Thornberry Director Grant or award +8,141 โ€” โ€”
Jun 22, 2026 Kralingen Bridget A. Van Director Grant or award +8,141 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.